Loading clinical trials...
Loading clinical trials...
A Phase I Clinical Study Evaluating the Safety and Efficacy of SCTC21C in Participants With CD38+ Hematologic Malignancies
Conditions
Interventions
SCTC21C
Locations
1
China
Beijing Chaoyang Hospital ,Capital Medical University
Beijing, Beijing Municipality, China
Start Date
February 28, 2024
Primary Completion Date
August 28, 2025
Completion Date
February 28, 2027
Last Updated
April 22, 2024
Lead Sponsor
Sinocelltech Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions